TEM · Tempus AI, Inc.
$61.18
+11.82 (+23.95%)
At close · Aug 19
Market Cap
$8.91B
Shares
180.43M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$49.36
Open$50.07
Day$49.35–51.10
52W close$41.55–103.25
Avg vol 30d4.7M
Short int33.2M · 18.4% float · 5.9d
Short vol54%
Last earningsJul 30, 2026
DataJun 2024–Aug 2026
Filing10-Q · Jul 30
Up next
Next earnings call
Oct 25, 2026
Est · unconfirmed
· in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Jul 30, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.64
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−14%
below
Price vs 50-day avg
−4%
below
RSI (14)
47
neutral
MACD trend
Positive
52-week position
13%
near low
Momentum
relative strength
1-month return
+1%
trailing
6-month return
−8%
trailing
YTD return
−16%
this year
Relative strength
−19%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $52 › 200d $57 — 200d above 50d
Institutional flow
Accumulating
+15% holders QoQ · +125 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
18.42% of float · ▲ +9.5% MoM · 5.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
496 holders — near 2-yr high, broad support
Squeeze score
79
high risk · 0–100
Fundamentals
Revenue growth
+83%
Y/Y
EPS growth
+77%
Y/Y
Free cash flow
$-239.1M
Balance sheet
$604.8M
net cash
Quant / Vol
risk profile
Volatility
66%
annualized · 1-yr
Max drawdown
−60%
past year
ATR
6.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Jul 30, 2026
Adjusted EBITDA
· full year 2026
Non-GAAP
Initiated
$65M
Prior guidance
period ended
· from the Earnings Call filed Jun 30, 2025
Full year 2025 revenue
· full year 2025
$1.26B
Adjusted EBITDA
· full year 2025
$5M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−14%
Bearish
Price vs 50-day avg
−4%
Neutral
RSI (14)
47
Neutral
MACD trend
Positive
Bullish
52-week position
13%
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $52 › 200d $57 — 200d above 50d
Institutional flow
Accumulating
+15% holders QoQ · +125 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
18.42% of float · ▲ +9.5% MoM · 5.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
496 holders — near 2-yr high, broad support
Price context
position in its 52-week range
Range low $42
Now $49 · 13%
Range high $103
vs 200-day avg -14%
vs 50-day avg -4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $8M | Q2 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Net income (loss) 5.64M
-3.9M Interest income
+10.28M Interest expense
+7.13M Depreciation
+18.86M Amortization
+309K Provision for (benefit from) income taxes
+2.86M Losses from equity method investments
-97.4M Fair value changes
+54.12M Stock-based compensation expense
+1.49M Employer payroll tax related to stock-based compensation
+990K Acquisition related expenses
-3.99M Amortization of technology license
+0K Franchise taxes related to IPO
+11.64M Loss on debt extinguishment
= Adjusted EBITDA 8.04M
|
|||
| Hereditary revenue growth | 5% | Q2 2026 | — |
| MRD volume | 9,000 | Q2 2026 | — |
|
|
|||
| Oncology volume growth | 31% | Q2 2026 | — |
|
|
|||
| Hereditary volume growth | 29% | Full Year 2025 | — |
| Net Revenue Retention | 126% | Q4 FY2025 | — |
| Total Remaining Contract Value | 1.1B | Q4 FY2025 | — |
| Total Contract Value (TCV) | 1.1B | full year 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TEM
this stock
Tempus AI, Inc.
|
$8.91B | -16.4% | +83.4% | — | 18.4% |
|
VEEV
Veeva Systems Inc
|
$39.43B | +8.7% | +28.1% | 43.0 | 4.5% |
|
PMDIY
Pro Medicus Ltd./ADR
|
$13.02B | -24.9% | — | — | 0.0% |
|
BTSG
BrightSpring Health Services, Inc.
|
$11.77B | +58.4% | +28.2% | 36.1 | 4.2% |
|
HQY
Healthequity, Inc.
|
$8.69B | +12.2% | +28.7% | 38.9 | 5.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TEM | -11.4% | +0.8% | -8.1% | +12.5% | -16.4% |
| SPY | -0.4% | +2.6% | +10.7% | +2.7% | +12.5% |
| vs SPY | -11.0% | -1.8% | -18.8% | +9.8% | -29.0% |
Key facts
CIK
1717115
CUSIP
88023B103
13F (30d)
448 filings
443 filers
Visit website
Investor relations